Medicare Enrolled

Dr. Maricarmen Quintero, M.D.

Rheumatology · Boynton Beach, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
6056 BOYNTON BEACH BLVD STE 145, Boynton Beach, FL 33437
5614391800
In practice since 2005 (20 years)
NPI: 1629064456 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Quintero from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Quintero? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Quintero

Dr. Maricarmen Quintero is a rheumatology specialist in Boynton Beach, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Quintero performed 46,446 Medicare services across 1,046 unique beneficiaries.

Between the years covered by Open Payments, Dr. Quintero received a total of $12,846 from 39 pharmaceutical and/or device companies across 823 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Quintero is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 38% volume in FL $12,846 industry payments

Medicare Practice Summary

Medicare Utilization ↗
46,446
Medicare services
Top 38% in FL for rheumatology
1,046
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,322 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
21,000 $4 $14
Romosozumab injection (Evenity) for osteoporosis 9,241 $8 $13
Denosumab injection (Prolia/Xgeva) 8,343 $18 $28
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
5,515 $10 $35
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
730 $94 $155
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
634 $1 $5
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
318 $59 $95
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
115 $105 $200
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
89 $41 $109
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
79 $129 $210
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
60 $6 $20
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
58 $69 $110
Knee X-ray, 3 views
An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures.
35 $26 $60
Injection, methylprednisolone acetate, 40 mg 34 $6 $10
X-ray of hand, minimum of 3 views
An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints.
26 $28 $67
Lower back and sciatic nerve injection
An injection of an anesthetic and/or steroid medication into the lower back and sciatic nerve. This procedure delivers medication directly to the nerve site.
23 $143 $298
X-ray of lower and sacral spine, 2-3 views
An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area.
23 $28 $68
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
23 $10 $35
Joint fluid aspiration or injection, small joint
Removal of fluid from a small joint or injection of medication into a small joint.
22 $24 $83
Shoulder X-ray, 2+ views
An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures.
19 $26 $65
Tendon injection at attachment site
A procedure involving the injection of medication into a tendon where it attaches to bone or muscle.
18 $44 $89
X-ray of upper spine, 4-5 views
An X-ray imaging test of the upper spine using 4 to 5 different views to visualize the bones and structures in that area.
16 $40 $90
X-ray of middle spine, 2 views
An X-ray imaging test that produces two views of the middle section of the spine to visualize the bones and joints.
13 $23 $68
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
12 $48 $100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.1% high complexity
85.7% medium
2.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$12,846
Total received (2018-2024)
Avg $1,835/year across 7 years
Top 37% in FL for rheumatology
39
Companies
823
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,846 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,522
2023
$2,206
2022
$2,336
2021
$1,145
2020
$432
2019
$1,985
2018
$2,221

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,836
Novartis Pharmaceuticals Corporation
$1,835
Amgen Inc.
$1,322
Janssen Biotech, Inc.
$1,231
PFIZER INC.
$1,076
E.R. Squibb & Sons, L.L.C.
$884
GlaxoSmithKline, LLC.
$829
UCB, Inc.
$522
Horizon Therapeutics plc
$491
AbbVie, Inc.
$426
AbbVie Inc.
$407
Radius Health, Inc.
$370
Genentech USA, Inc.
$266
Lilly USA, LLC
$206
Boehringer Ingelheim Pharmaceuticals, Inc.
$131
Alvogen Inc
$111
Genentech, Inc.
$110
AstraZeneca Pharmaceuticals LP
$99
Horizon Pharma plc
$92
Actelion Pharmaceuticals US, Inc.
$88
Mallinckrodt Hospital Products Inc.
$58
Aurinia Pharma U.S., Inc.
$55
Smith+Nephew, Inc.
$40
Fresenius Kabi USA, LLC
$40
Sobi, Inc
$34
Organon LLC
$32
GENZYME CORPORATION
$30
ANI Pharmaceuticals, Inc.
$29
Ultragenyx Pharmaceutical Inc.
$25
Fidia Pharma USA Inc.
$23
Kiniksa Pharmaceuticals, Ltd.
$23
Alexion Pharmaceuticals, Inc.
$22
Kiniksa Pharmaceuticals International, plc
$20
DePuy Synthes Sales Inc.
$16
Novo Nordisk Inc
$16
Kowa Pharmaceuticals America, Inc.
$15
Regeneron Healthcare Solutions, Inc.
$13
MEDEXUS PHARMA, INC.
$12
SANOFI-AVENTIS U.S. LLC
$12
Top 3 companies account for 38.9% of total payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CRYSVITA · Cimzia · EVENITY · Enbrel · FORTEO · HADLIMA · HUMIRA · HYMOVIS · Humira · IDACIO · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · OFEV · OPSUMIT · ORENCIA · ORTHOVISC · Otezla · PURIFIED CORTROPHIN GEL · Prolia · REAL INTELLIGENCE · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · Seglentis · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tymlos · Wegovy · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $28 per 100 Medicare services performed
Looking for a rheumatology specialist in Boynton Beach?
Compare rheumatologists in the Boynton Beach area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
63
Per 100K population
4.2
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
3.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Quintero is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Quintero experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Quintero performed 21,000 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Quintero receive payments from pharmaceutical companies?
Yes. Dr. Quintero received a total of $12,846 from 39 companies across 823 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Quintero's costs compare to other rheumatologists in Boynton Beach?
Dr. Quintero's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Quintero) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →